Literature DB >> 760249

Peripheral nerve structures of experimental diabetes rats and the effect of insulin treatment.

S Yagihashi, K Kudo, M Nishihira.   

Abstract

The peripheral nerves of alloxan and streptozotocin diabetes rats six months after the induction of diabetes were morphologically investigated. The effect of insulin treatment was also examined. Prominent segmental demyelination and remyelination were observed in both alloxan and streptozotocin diabetes rats by isolated nerve fiber studies. Axonal degeneration and globular swelling were also recognized in some nerve fibers. Transmission electron microscopic findings were characterized by the figures of destructed myelin sheaths and axons. Reduplication and thickening of basal lamina of vasa nervorum were noted in the diabetes rats. Scanning electron microscopy revealed three dimensional architectures of degenerated nerve fibers and rough surface of Schwann cells in the diabetes rats. Insulin treated diabetes rats showed less structural changes of nerve fibers. It was indicated that the peripheral nerve lesions of experimental diabetes rats were caused by metabolic impairment of both axons and Schwann cells. Insulin treatment seemed to be effective on the experimental diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760249     DOI: 10.1620/tjem.127.35

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  10 in total

1.  Restoration of ultrastructural and biochemical changes in alloxan-induced diabetic rat sciatic nerve on treatment with Na3VO4 and Trigonella--a promising antidiabetic agent.

Authors:  Anju Preet; Bihari L Gupta; Mohamed R Siddiqui; Pramod K Yadava; Nazma Zaheer Baquer
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

Review 2.  Animal models of peripheral neuropathies.

Authors:  Ahmet Höke
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

3.  Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.

Authors:  K R Gillon; J N Hawthorne; D R Tomlinson
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

4.  Peripheral nerve axonal dwindling with concomitant myelin sheath hypertrophy in experimentally induced diabetes.

Authors:  G E Mattingly; V W Fischer
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

5.  Peripheral neuropathy following prolonged exposure to streptozotocin-induced diabetes in rats: a teased nerve fiber study.

Authors:  G E Mattingly; V W Fischer
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

6.  Association of chronic diabetes and hypertension in sural nerve morphometry: an experimental study.

Authors:  Luciana Sayuri Sanada; Marcelo Rodrigo Tavares; Karina Laurenti Sato; Renata da Silva Ferreira; Milena Cardoso Maia Neubern; Jaci Ayrton Castania; Helio Cesar Salgado; Valéria Paula Sassoli Fazan
Journal:  Diabetol Metab Syndr       Date:  2015-02-15       Impact factor: 3.320

7.  Insulin-ameliorated peripheral motor neuropathy in spontaneously diabetic WBN/Kob rats.

Authors:  Kiyokazu Ozaki; Shotaro Yamano; Tetsuro Matsuura; Isao Narama
Journal:  J Vet Med Sci       Date:  2013-07-07       Impact factor: 1.267

8.  Effect of deoxycorticosterone acetate-salt-induced hypertension on diabetic peripheral neuropathy in alloxan-induced diabetic WBN/Kob rats.

Authors:  Kiyokazu Ozaki; Hiroko Hamano; Tetsuro Matsuura; Isao Narama
Journal:  J Toxicol Pathol       Date:  2015-09-20       Impact factor: 1.628

9.  Advances in diet-induced rodent models of metabolically acquired peripheral neuropathy.

Authors:  Stéphanie A Eid; Eva L Feldman
Journal:  Dis Model Mech       Date:  2021-11-11       Impact factor: 5.758

10.  Effect of combined dyslipidemia and hyperglycemia on diabetic peripheral neuropathy in alloxan-induced diabetic WBN/Kob rats.

Authors:  Kiyokazu Ozaki; Yui Terayama; Tetsuro Matsuura; Isao Narama
Journal:  J Toxicol Pathol       Date:  2018-02-12       Impact factor: 1.628

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.